SCHEMBL11602002

SCHEMBL11602002

CCOC(=O)c1ccc(COc2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.61
RXRA P19793 1/20 0.60
RXRB P28702 1/20 0.60
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
MAPT P10636 4/20 0.59
ALDH1A1 P00352 3/20 0.59
MAOB P27338 1/20 0.58
HTT P42858 2/20 0.57
RAB9A P51151 2/20 0.57
GAA P10253 1/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
ESR1 P03372 1/20 0.57
CA7 P43166 1/20 0.57
CA9 Q16790 1/20 0.57
ESR2 Q92731 1/20 0.57
CA14 Q9ULX7 1/20 0.57
LMNA P02545 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL340618 0.94 MAOB (0.67) SMN1; SMN2RXRARXRBKMT2AMAPT
SCHEMBL977234 0.90 SRD5A2 (0.68) SMN1; SMN2RXRARXRBMAPTALDH1A1
SCHEMBL11601531 0.88 MAOB (0.69) SMN1; SMN2RXRARXRBMEN1KMT2A
SCHEMBL4058623 0.88 MAOB (0.69) SMN1; SMN2RXRARXRBMEN1KMT2A
SCHEMBL978523 0.87 MAOB (0.58) SMN1; SMN2RXRARXRBMEN1KMT2A
SCHEMBL1303551 0.86 NPC1 (0.68) SMN1; SMN2RXRARXRBMEN1KMT2A
SCHEMBL11603134 0.85 MAOB (0.68) SMN1; SMN2RXRARXRBMEN1KMT2A
SCHEMBL11602775 0.85 MAOB (0.68) SMN1; SMN2RXRARXRBMEN1KMT2A
SCHEMBL11601734 0.85 MAOB (0.68) SMN1; SMN2RXRARXRBMEN1KMT2A
SCHEMBL11255125 0.85 MAPT (0.64) SMN1; SMN2MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4098816-A HYPOGLYCEMIC AGENTS AND ANTILIPEMIC AGENTS BEECHAM GROUP LIMITED (GB) 1978-07-04 US disclosed